Spinocerebellar ataxia type 6

Handbook of Clinical Neurology

Volumn 103, Issue , 2012, Pages 461-473

  Solodkin, Ana ^a   Gomez, Christopher M ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79961154818     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-51892-7.00029-2     Document Type: Chapter

References (134)

1. Alonso I., Barros J., Tuna A., et al. Phenotypes of spinocerebellar ataxia type 6 and familial hemiplegic migraine caused by a unique CACNA1A missense mutation in patients from a large family. Arch Neurol 2003, 60:610-614.
2. Anderson J.H., Yavuz M.C., Kazar B.M., et al. The vestibulo-ocular reflex and velocity storage in spinocerebellar ataxia 8. Arch Ital Biol 2002, 140:323-329.
3. Baloh R.W., Yue Q., Furman J.M., et al. Familial episodic ataxia: clinical heterogeneity in four families linked to chromosome 19p. Ann Neurol 1997, 41:8-16.
4. Bang O.Y., Huh K., Lee P.H., et al. Clinical and neuroradiological features of patients with spinocerebellar ataxias from Korean kindreds. Arch Neurol 2003, 60:1566-1574.
5. Basu P., Chattopadhyay B., Gangopadhaya P.K., et al. Analysis of CAG repeats in SCA1, SCA2, SCA3, SCA6, SCA7 and DRPLA loci in spinocerebellar ataxia patients and distribution of CAG repeats at the SCA1, SCA2 and SCA6 loci in nine ethnic populations of eastern India. Hum Genet 2000, 106:597-604.
6. Battistini S., Stenirri S., Piatti M., et al. A new CACNA1A gene mutation in acetazolamide-responsive familial hemiplegic migraine and ataxia. Neurology 1999, 53:38-43.
7. Boesch S.M., Frauscher B., Brandauer E., et al. Restless legs syndrome and motor activity during sleep in spinocerebellar ataxia type 6. Sleep Med 2006, 7:529-532.
8. Brusco A., Gellera C., Cagnoli C., et al. Molecular genetics of hereditary spinocerebellar ataxia: mutation analysis of spinocerebellar ataxia genes and CAG/CTG repeat expansion detection in 225 Italian families. Arch Neurol 2004, 61:727-733.
9. Bryer A., Krause A., Bill P., et al. The hereditary adult-onset ataxias in South Africa. J Neurol Sci 2003, 216:47-54.
10. Burgess D.L., Jones J.M., Meisler M.H., et al. Mutation of the Ca2+ channel beta subunit gene Cchb4 is associated with ataxia and seizures in the lethargic (lh) mouse. Cell 1997, 88:385-392.
11. Catterall W.A., Few A.P. Calcium channel regulation and presynaptic plasticity. Neuron 2008, 59:882-901.
12. Chen J.T., Lin Y.Y., Lee Y.C., et al. Prolonged central motor conduction time of lower limb muscle in spinocerebellar ataxia 6. J Clin Neurosci 2004, 11:381-383.
13. Christova P., Anderson J.H., Gomez C.M. Impaired eye movements in presymptomatic spinocerebellar ataxia type 6. Arch Neurol 2008, 65:530-536.
14. Collier M.L., Ji G., Wang Y., et al. Calcium-induced calcium release in smooth muscle: loose coupling between the action potential and calcium release. J Gen Physiol 2000, 115:653-662.
15. Craig K., Keers S.M., Archibald K., et al. Molecular epidemiology of spinocerebellar ataxia type 6. Ann Neurol 2004, 55:752-755.
16. Craig K., Takiyama Y., Soong B.W., et al. Pathogenic expansions of the SCA6 locus are associated with a common CACNA1A haplotype across the globe: founder effect or predisposing chromosome?. Eur J Hum Genet 2008, 16:841-847.
17. Ducros A., Denier C., Joutel A., et al. Recurrence of the T666M calcium channel CACNA1A gene mutation in familial hemiplegic migraine with progressive cerebellar ataxia. Am J Hum Genet 1999, 64:89-98.
18. Duenas A.M., Goold R., Giunti P. Molecular pathogenesis of spinocerebellar ataxias. Brain 2006, 129:1357-1370.
19. Forman M.S., Trojanowski J.Q., Lee V.M. Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs. Nat Med 2004, 10:1055-1063.
20. Friend K.L., Crimmins D., Phan T.G., et al. Detection of a novel missense mutation and second recurrent mutation in the CACNA1A gene in individuals with EA2 and FHM. Hum Genet 1999, 105:261-265.
21. Frontali M., Novelletto A., Annesi G., et al. CAG repeat instability, cryptic sequence variation and pathogeneticity: evidence from different loci. Philos Trans R Soc Lond B Biol Sci 1999, 354:1089-1094.
22. Gardner K. The genetic basis of migraine: how much do we know?. Can J Neurol Sci 1999, 26:S37-S43.
23. Garrard P., Martin N.H., Giunti P., et al. Cognitive and social cognitive functioning in spinocerebellar ataxia: a preliminary characterization. J Neurol 2008, 255:398-405.
24. Gatchel J.R., Zoghbi H.Y. Diseases of unstable repeat expansion: mechanisms and common principles. Nat Rev Genet 2005, 6:743-755.
25. Geschwind D.H., Perlman S., Figueroa K.P., et al. Spinocerebellar ataxia type 6. Frequency of the mutation and genotype-phenotype correlations. Neurology 1997, 49:1247-1251.
26. Ghosh A., Greenberg M.E. Calcium signaling in neurons: molecular mechanisms and cellular consequences. Science 1995, 268:239-247.
27. Ghosh A., Ginty D.D., Bading H., et al. Calcium regulation of gene expression in neuronal cells. J Neurobiol 1994, 25:294-303.
28. Globas C., Bosch S., Zuhlke C., et al. The cerebellum and cognition. Intellectual function in spinocerebellar ataxia type 6 (SCA6). J Neurol 2003, 250:1482-1487.
29. Globas C., du Montcel S.T., Baliko L., et al. Early symptoms in spinocerebellar ataxia type 1, 2, 3, and 6. Mov Disord 2008, 23:2232-2238.
30. Goldin A.L., Barchi R.L., Caldwell J.H., et al. Nomenclature of voltage-gated sodium channels. Neuron 2000, 28:365-368.
31. Gomez C.M., Subramony S.H. Dominantly inherited ataxias. Semin Pediatr Neurol 2003, 10:210-222.
32. Gomez C.M., Thompson R.M., Gammack J.T., et al. Spinocerebellar ataxia type 6: gaze-evoked and vertical nystagmus, Purkinje cell degeneration, and variable age of onset. Ann Neurol 1997, 42:933-950.
33. Greenberg D.A. Calcium channels in neurological disease. Ann Neurol 1997, 42:275-282.
34. Griggs R.C., Nutt J.G. Episodic ataxias as channelopathies. Ann Neurol 1995, 37:285-287.
35. Gusella J.F., Persichetti F., MacDonald M.E. The genetic defect causing Huntington's disease: repeated in other contexts?. Mol Med 1997, 3:238-246.
36. Hofmann F., Biel M., Flockerzi V. Molecular basis for Ca2+ channel diversity. Annu Rev Neurosci 1994, 17:399-418.
37. Honjo K., Ohshita T., Kawakami H., et al. Quantitative assessment of cerebral blood flow in genetically confirmed spinocerebellar ataxia type 6. Arch Neurol 2004, 61:933-937.
38. Howell M.J., Mahowald M.W., Gomez C.M. Evaluation of sleep and daytime somnolence in spinocerebellar ataxia type 6 (SCA6). Neurology 2006, 66:1430-1431.
39. Ikeuchi T., Takano H., Koide R., et al. Spinocerebellar ataxia type 6: CAG repeat expansion in alpha1a voltage-dependent calcium channel gene and clinical variations in Japanese population. Ann Neurol 1997, 42:879-884.
40. Ishikawa K., Tanaka H., Saito M., et al. Japanese families with autosomal dominant pure cerebellar ataxia map to chromosome 19p13.1-p13.2 and are strongly associated with mild CAG expansions in the spinocerebellar ataxia type 6 gene in chromosome 19p13.1. Am J Hum Genet 1997, 61:336-346.
41. Ishikawa K., Watanabe M., Yoshizawa K., et al. Clinical, neuropathological, and molecular study in two families with spinocerebellar ataxia type 6 (SCA6). J Neurol Neurosurg Psychiatry 1999, 67:86-89.
42. Jana N.R., Nukina N. Recent advances in understanding the pathogenesis of polyglutamine diseases: involvement of molecular chaperones and ubiquitin-proteasome pathway. J Chem Neuroanat 2003, 26:95-101.
43. Jen J. Calcium channelopathies in the central nervous system. Curr Opin Neurobiol 1999, 9:274-280.
44. Jen J.C., Yue Q., Karrim J., et al. Spinocerebellar ataxia type 6 with positional vertigo and acetazolamide responsive episodic ataxia. J Neurol Neurosurg Psychiatry 1998, 65:565-568.
45. Jiang H., Tang B., Xia K., et al. Spinocerebellar ataxia type 6 in Mainland China: molecular and clinical features in four families. J Neurol Sci 2005, 236:25-29.
46. Jodice C., Mantuano E., Veneziano L., et al. Episodic ataxia type 2 (EA2) and spinocerebellar ataxia type 6 (SCA6) due to CAG repeat expansion in the CACNA1A gene on chromosome 19p. Hum Mol Genet 1997, 6:1973-1978.
47. Katayama T., Ogura Y., Aizawa H., et al. Nineteen CAG repeats of the SCA6 gene in a Japanese patient presenting with ataxia. J Neurol 2000, 247:711-712.
48. Kawai Y., Suenaga M., Watanabe H., et al. Prefrontal hypoperfusion and cognitive dysfunction correlates in spinocerebellar ataxia type 6. J Neurol Sci 2008, 271:68-74.
49. Kelly J.G., O'Malley K. Calcium antagonists in the elderly. Drugs Aging 1993, 3:400-407.
50. Kennedy L., Shelbourne P.F. Dramatic mutation instability in HD mouse striatum: does polyglutamine load contribute to cell-specific vulnerability in Huntington's disease?. Hum Mol Genet 2000, 9:2539-2544.
51. Klement I.A., Skinner P.J., Kaytor M.D., et al. Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice. Cell 1998, 95:41-53.
52. Koeppen A.H. The pathogenesis of spinocerebellar ataxia. Cerebellum 2005, 4:62-73.
53. Kordasiewicz H.B., Thompson R.M., Clark H.B., et al. C-termini of P/Q-type Ca2+ channel alpha1a subunits translocate to nuclei and promote polyglutamine-mediated toxicity. Hum Mol Genet 2006, 15:1587-1599.
54. Kors E.E., Terwindt G.M., Vermeulen F.L., et al. Delayed cerebral edema and fatal coma after minor head trauma: role of the CACNA1A calcium channel subunit gene and relationship with familial hemiplegic migraine. Ann Neurol 2001, 49:753-760.
55. Kubodera T., Yokota T., Ohwada K., et al. Proteolytic cleavage and cellular toxicity of the human alpha1a calcium channel in spinocerebellar ataxia type 6. Neurosci Lett 2003, 341:74-78.
56. Kumagai R., Kaseda Y., Kawakami H., et al. Electrophysiological studies in spinocerebellar ataxia type 6: a statistical approach. NeuroReport 2000, 11:969-972.
57. Kurokawa-Kuroda T., Ogata K., Suga R., et al. Altered soleus responses to magnetic stimulation in pure cerebellar ataxia. Clin Neurophysiol 2007, 118:1198-1203.
58. La Spada A.R., Taylor J.P. Polyglutamines placed into context. Neuron 2003, 38:681-684.
59. Lee A., Wong S.T., Gallagher D., et al. Ca2+/calmodulin binds to and modulates P/Q-type calcium channels. Nature 1999, 399:155-159.
60. Lee A., Scheuer T., Catterall W.A. Ca2+/calmodulin-dependent facilitation and inactivation of P/Q-type Ca2+ channels. J Neurosci 2000, 20:6830-6838.
61. Leggo J., Dalton A., Morrison P.J., et al. Analysis of spinocerebellar ataxia types 1, 2, 3, and 6, dentatorubral-pallidoluysian atrophy, and Friedreich's ataxia genes in spinocerebellar ataxia patients in the UK. J Med Genet 1997, 34:982-985.
62. Lindquist S.G., Norremolle A., Hjermind L.E., et al. Meiotic CAG repeat instability in spinocerebellar ataxia type 6: maternally transmitted elongation in a presumed sporadic case. J Neurol Sci 2006, 241:95-98.
63. Lipinski M.M., Yuan J. Mechanisms of cell death in polyglutamine expansion diseases. Curr Opin Pharmacol 2004, 4:85-90.
64. Lukas C., Schols L., Bellenberg B., et al. Dissociation of grey and white matter reduction in spinocerebellar ataxia type 3 and 6: a voxel-based morphometry study. Neurosci Lett 2006, 408:230-235.
65. Manto M.U. The wide spectrum of spinocerebellar ataxias (SCAs). Cerebellum 2005, 4:2-6.
66. Mantuano E., Veneziano L., Jodice C., et al. Spinocerebellar ataxia type 6 and episodic ataxia type 2: differences and similarities between two allelic disorders. Cytogenet Genome Res 2003, 100:147-153.
67. Mariotti C., Di Donato S. Cerebellar/spinocerebellar syndromes. Neurol Sci 2001, 22:S88-S92.
68. Mariotti C., Gellera C., Grisoli M., et al. Pathogenic effect of an intermediate-size SCA-6 allele (CAG)(19) in a homozygous patient. Neurology 2001, 57:1502-1504.
69. Maruyama H., Izumi Y., Morino H., et al. Difference in disease-free survival curve and regional distribution according to subtype of spinocerebellar ataxia: a study of 1, 286 Japanese patients. Am J Med Genet 2002, 114:578-583.
70. Maschke M., Oehlert G., Xie T.D., et al. Clinical feature profile of spinocerebellar ataxia type 1-8 predicts genetically defined subtypes. Mov Disord 2005, 20:1405-1412.
71. Matsumura R., Futamura N., Fujimoto Y., et al. Spinocerebellar ataxia type 6. Molecular and clinical features of 35 Japanese patients including one homozygous for the CAG repeat expansion. Neurology 1997, 49:1238-1243.
72. Matsumura R., Futamura N., Ando N., et al. Frequency of spinocerebellar ataxia mutations in the Kinki district of Japan. Acta Neurol Scand 2003, 107:38-41.
73. Matsuyama Z., Kawakami H., Maruyama H., et al. Molecular features of the CAG repeats of spinocerebellar ataxia 6 (SCA6). Hum Mol Genet 1997, 6:1283-1287.
74. Matsuyama Z., Wakamori M., Mori Y., et al. Direct alteration of the P/Q-type Ca2+ channel property by polyglutamine expansion in spinocerebellar ataxia 6. J Neurosci 1999, 19:RC14.
75. McCrory P.R., Berkovic S.F. Concussive convulsions. Incidence in sport and treatment recommendations. Sports Med 1998, 25:131-136.
76. Miller R.J. Calcium channels prove to be a real headache. Trends Neurosci 1997, 20:189-192.
77. Montagna P. Molecular genetics of migraine headaches: a review. Cephalalgia 2000, 20:3-14.
78. Muchowski P.J. Protein misfolding, amyloid formation, and neurodegeneration: a critical role for molecular chaperones?. Neuron 2002, 35:9-12.
79. Murata Y., Kawakami H., Yamaguchi S., et al. Characteristic magnetic resonance imaging findings in spinocerebellar ataxia 6. Arch Neurol 1998, 55:1348-1352.
80. Nucifora F.C., Ellerby L.M., Wellington C.L., et al. Nuclear localization of a non-caspase truncation product of atrophin-1, with an expanded polyglutamine repeat, increases cellular toxicity. J Biol Chem 2003, 278:13047-13055.
81. Ogawa M. Pharmacological treatments of cerebellar ataxia. Cerebellum 2004, 3:107-111.
82. Ogawa M., Shigeto H., Yamamoto T., et al. D-cycloserine for the treatment of ataxia in spinocerebellar degeneration. J Neurol Sci 2003, 210:53-56.
83. Okazawa H. Polyglutamine diseases: a transcription disorder?. Cell Mol Life Sci 2003, 60:1427-1439.
84. Ophoff R.A., Terwindt G.M., Vergouwe M.N., et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 1996, 87:543-552.
85. Ophoff R.A., Terwindt G.M., Vergouwe M.N., et al. A 3-Mb region for the familial hemiplegic migraine locus on 19p13.1-p13.2: exclusion of PRKCSH as a candidate gene. Dutch Migraine Genetic Research Group. Eur J Hum Genet 1996, 4:321-328.
86. Perlman S.L. Symptomatic and disease-modifying therapy for the progressive ataxias. Neurologist 2004, 10:275-289.
87. Piedras-Renteria E.S., Watase K., Harata N., et al. Increased expression of alpha 1A Ca2+ channel currents arising from expanded trinucleotide repeats in spinocerebellar ataxia type 6. J Neurosci 2001, 21:9185-9193.
88. Pietrobon D. Calcium channels and channelopathies of the central nervous system. Mol Neurobiol 2002, 25:31-50.
89. Pujana M.A., Corral J., Gratacos M., et al. Spinocerebellar ataxias in Spanish patients: genetic analysis of familial and sporadic cases. The Ataxia Study Group. Hum Genet 1999, 104:516-522.
90. Restituito S., Thompson R.M., Eliet J., et al. The polyglutamine expansion in spinocerebellar ataxia type 6 causes a beta subunit-specific enhanced activation of P/Q-type calcium channels in Xenopus oocytes. J Neurosci 2000, 20:6394-6403.
91. Riess O., Schols L., Bottger H., et al. SCA6 is caused by moderate CAG expansion in the alpha1a-voltage-dependent calcium channel gene. Hum Mol Genet 1997, 6:1289-1293.
92. Ross C.A., Poirier M.A. Protein aggregation and neurodegenerative disease. Nat Med 2004, 10:S10-S17.
93. Rub U., Brunt E.R., Petrasch-Parwez E., et al. Degeneration of ingestion-related brainstem nuclei in spinocerebellar ataxia type 2, 3, 6 and 7. Neuropathol Appl Neurobiol 2006, 32:635-649.
94. Saegusa H., Wakamori M., Matsuda Y., et al. Properties of human Cav2.1 channel with a spinocerebellar ataxia type 6 mutation expressed in Purkinje cells. Mol Cell Neurosci 2007, 34:261-270.
95. Sakuma K., Adachi Y., Fukuda H., et al. Triple stimulation technique in patients with spinocerebellar ataxia type 6. Clin Neurophysiol 2005, 116:2586-2591.
96. Sasaki H., Kojima H., Yabe I., et al. Neuropathological and molecular studies of spinocerebellar ataxia type 6 (SCA6). Acta Neuropathol (Berl) 1998, 95:199-204.
97. Sasaki H., Yabe I., Tashiro K. The hereditary spinocerebellar ataxias in Japan. Cytogenet Genome Res 2003, 100:198-205.
98. Schelhaas H.J., Van de Warrenburg B.P., Kremer H.P., et al. Neuromuscular transmission in SCA6. Ann Neurol 2004, 55:451-452.
99. Schmitz-Hubsch T., Coudert M., Bauer P., et al. Spinocerebellar ataxia types 1, 2, 3, and 6: disease severity and nonataxia symptoms. Neurology 2008, 71:982-989.
100. Schols L., Kruger R., Amoiridis G., et al. Spinocerebellar ataxia type 6: genotype and phenotype in German kindreds. J Neurol Neurosurg Psychiatry 1998, 64:67-73.
101. Schols L., Linnemann C., Globas C. Electrophysiology in spinocerebellar ataxias: spread of disease and characteristic findings. Cerebellum 2008, 7:198-203.
102. Sethi K.D., Jankovic J. Dystonia in spinocerebellar ataxia type 6. Mov Disord 2002, 17:150-153.
103. Shimazaki H., Takiyama Y., Sakoe K., et al. Meiotic instability of the CAG repeats in the SCA6/CACNA1A gene in two Japanese SCA6 families. J Neurol Sci 2001, 185:101-107.
104. Shizuka M., Watanabe M., Ikeda Y., et al. Molecular analysis of a de novo mutation for spinocerebellar ataxia type 6 and (CAG)n repeat units in normal elder controls. J Neurol Sci 1998, 161:85-87.
105. Sinke R.J., Ippel E.F., Diepstraten C.M., et al. Clinical and molecular correlations in spinocerebellar ataxia type 6: a study of 24 Dutch families. Arch Neurol 2001, 58:1839-1844.
106. Snoek J.W., Minderhoud J.M., Wilmink J.T. Delayed deterioration following mild head injury in children. Brain 1984, 107:15-36.
107. Snutch T.P., Reiner P.B. Ca2+ channels: diversity of form and function. Curr Opin Neurobiol 1992, 2:247-253.
108. Stevanin G., Durr A., David G., et al. Clinical and molecular features of spinocerebellar ataxia type 6. Neurology 1997, 49:1243-1246.
109. Storey E., du Sart D., Shaw J.H., et al. Frequency of spinocerebellar ataxia types 1, 2, 3, 6, and 7 in Australian patients with spinocerebellar ataxia. Am J Med Genet 2000, 95:351-357.
110. Suenaga M., Kawai Y., Watanabe H., et al. Cognitive impairment in spinocerebellar ataxia type 6. J Neurol Neurosurg Psychiatry 2008, 79:496-499.
111. Sutton K.G., McRory J.E., Guthrie H., et al. P/Q-type calcium channels mediate the activity-dependent feedback of syntaxin-1A. Nature 1999, 401:800-804.
112. Takahashi H., Ishikawa K., Tsutsumi T., et al. A clinical and genetic study in a large cohort of patients with spinocerebellar ataxia type 6. J Hum Genet 2004, 49:256-264.
113. Takeyama K., Ito S., Yamamoto A., et al. Androgen-dependent neurodegeneration by polyglutamine-expanded human androgen receptor in Drosophila. Neuron 2002, 35:855-864.
114. Takiyama Y., Sakoe K., Namekawa M., et al. A Japanese family with spinocerebellar ataxia type 6 which includes three individuals homozygous for an expanded CAG repeat in the SCA6/CACNL1A4 gene. J Neurol Sci 1998, 158:141-147.
115. Teive H.A., Munhoz R.P., Raskin S., et al. Spinocerebellar ataxia type 6 in Brazil. Arq Neuropsiquiatr 2008, 66:691-694.
116. Teo J.T., Schneider S.A., Cheeran B.J., et al. Prolonged cortical silent period but normal sensorimotor plasticity in spinocerebellar ataxia 6. Mov Disord 2008, 23:378-385.
117. Terwindt G.M., Ophoff R.A., Haan J., et al. Familial hemiplegic migraine: a clinical comparison of families linked and unlinked to chromosome 19.DMG RG. Cephalalgia 1996, 16:153-155.
118. Terwindt G.M., Ophoff R.A., Haan J., et al. Migraine, ataxia and epilepsy: a challenging spectrum of genetically determined calcium channelopathies. Dutch Migraine Genetics Research Group. Eur J Hum Genet 1998, 6:297-307.
119. Toru S., Murakoshi T., Ishikawa K., et al. Spinocerebellar ataxia type 6 mutation alters P-type calcium channel function. J Biol Chem 2000, 275:10893-10898.
120. Tsuchiya K., Oda T., Yoshida M., et al. Degeneration of the inferior olive in spinocerebellar ataxia 6 may depend on disease duration: report of two autopsy cases and statistical analysis of autopsy cases reported to date. Neuropathology 2005, 25:125-135.
121. Tsuji S. Clinical applications of transcranial magnetic stimulation for the treatment of various neurological diseases. Rinsho Shinkeigaku 2005, 45:831-833.
122. Tully K., Treistman S.N. Distinct intracellular calcium profiles following influx through N- versus L-type calcium channels: role of Ca2+-induced Ca2+ release. J Neurophysiol 2004, 92:135-143.
123. van de Warrenburg B.P., Sinke R.J., Verschuuren-Bemelmans C.C., et al. Spinocerebellar ataxias in the Netherlands: prevalence and age at onset variance analysis. Neurology 2002, 58:702-708.
124. van de Warrenburg B.P., Hendriks H., Durr A., et al. Age at onset variance analysis in spinocerebellar ataxias: a study in a Dutch-French cohort. Ann Neurol 2005, 57:505-512.
125. Wang P.S., Liu R.S., Yang B.H., et al. Regional patterns of cerebral glucose metabolism in spinocerebellar ataxia type 2, 3 and 6: a voxel-based FDG-positron emission tomography analysis. J Neurol 2007, 254:838-845.
126. Watase K., Barrett C.F., Miyazaki T., et al. Spinocerebellar ataxia type 6 knockin mice develop a progressive neuronal dysfunction with age-dependent accumulation of mutant cav2.1 channels. Proc Natl Acad Sci U S A 2008, 105:11987-11992.
127. Westenbroek R.E., Sakurai T., Elliott E.M., et al. Immunochemical identification and subcellular distribution of the alpha 1A subunits of brain calcium channels. J Neurosci 1995, 15:6403-6418.
128. Wullner U., Reimold M., Abele M., et al. Dopamine transporter positron emission tomography in spinocerebellar ataxias type 1, 2, 3, and 6. Arch Neurol 2005, 62:1280-1285.
129. Yabe I., Sasaki H., Yamashita I., et al. Periodic alternating nystagmus in spinocerebellar ataxia type 6 (SCA 6). Rinsho Shinkeigaku 1998, 38:512-515.
130. Yang Q., Hashizume Y., Yoshida M., et al. Morphological Purkinje cell changes in spinocerebellar ataxia type 6. Acta Neuropathol (Berl) 2000, 100:371-376.
131. Ying S.H., Choi S.I., Lee M., et al. Relative atrophy of the flocculus and ocular motor dysfunction in SCA2 and SCA6. Ann N Y Acad Sci 2005, 1039:430-435.
132. Yue Q., Jen J.C., Nelson S.F., et al. Progressive ataxia due to a missense mutation in a calcium-channel gene. Am J Hum Genet 1997, 61:1078-1087.
133. Zhuchenko O., Bailey J., Bonnen P., et al. Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel. Nat Genet 1997, 15:62-69.
134. Zoghbi H.Y. CAG repeats in SCA6. Anticipating new clues. Neurology 1997, 49:1196-1199.